BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Kountouras J, Deretzi G, Gavalas E, Zavos C, Polyzos SA, Kazakos E, Giartza-Taxidou E, Vardaka E, Kountouras C, Katsinelos P. A proposed role of human defensins in Helicobacter pylori-related neurodegenerative disorders. Med Hypotheses. 2014;82:368-373. [PMID: 24472867 DOI: 10.1016/j.mehy.2013.12.025] [Cited by in Crossref: 23] [Cited by in F6Publishing: 23] [Article Influence: 3.3] [Reference Citation Analysis]
Number Citing Articles
1 Deretzi G, Kountouras J, Polyzos SA, Koutlas E, Pelidou S, Xeromerisiou G, Zavos C, Tsiptsios I. Polyautoimmunity in a Greek cohort of multiple sclerosis. Acta Neurol Scand 2015;131:225-30. [DOI: 10.1111/ane.12308] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
2 Huang SS, Chang NS. Phosphorylation/de-phosphorylation in specific sites of tumor suppressor WWOX and control of distinct biological events. Exp Biol Med (Maywood) 2018;243:137-47. [PMID: 29310447 DOI: 10.1177/1535370217752350] [Cited by in Crossref: 16] [Cited by in F6Publishing: 15] [Article Influence: 5.3] [Reference Citation Analysis]
3 Emery DC, Shoemark DK, Batstone TE, Waterfall CM, Coghill JA, Cerajewska TL, Davies M, West NX, Allen SJ. 16S rRNA Next Generation Sequencing Analysis Shows Bacteria in Alzheimer's Post-Mortem Brain. Front Aging Neurosci. 2017;9:195. [PMID: 28676754 DOI: 10.3389/fnagi.2017.00195] [Cited by in Crossref: 120] [Cited by in F6Publishing: 114] [Article Influence: 30.0] [Reference Citation Analysis]
4 Danilova YV, Shagimardanova EI, Margulis AB, Toymentseva AA, Balaban NP, Rudakova NL, Rizvanov AA, Sharipova MR, Palotás A. Bacterial enzymes effectively digest Alzheimer's β-amyloid peptide. Brain Res Bull 2014;108:113-7. [PMID: 25262575 DOI: 10.1016/j.brainresbull.2014.08.009] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.4] [Reference Citation Analysis]
5 Kountouras J, Papaefthymiou A, Polyzos SA, Vardaka E, Boziki M, Kyriakopoulos A, Sampsonas F, Agrotis G, Karafyllidou K, Doulberis M. Impact of Helicobacter pylori-related Microbial Dysbiosis in the Pathogenesis of Metabolic Syndrome and Gastrointestinal Dysmotility Disorders. J Neurogastroenterol Motil 2021;27:653-4. [PMID: 34642287 DOI: 10.5056/jnm21059] [Reference Citation Analysis]
6 Doulberis M, Kotronis G, Thomann R, Polyzos SA, Boziki M, Gialamprinou D, Deretzi G, Katsinelos P, Kountouras J. Review: Impact of Helicobacter pylori on Alzheimer's disease: What do we know so far? Helicobacter. 2018;23. [PMID: 29181894 DOI: 10.1111/hel.12454] [Cited by in Crossref: 45] [Cited by in F6Publishing: 42] [Article Influence: 11.3] [Reference Citation Analysis]
7 Boziki M, Grigoriadis N, Papaefthymiou A, Doulberis M, Polyzos SA, Gavalas E, Deretzi G, Karafoulidou E, Kesidou E, Taloumtzis C, Theotokis P, Sofou E, Katsinelos P, Vardaka E, Fludaras I, Touloumtzi M, Koukoufiki A, Simeonidou C, Liatsos C, Kountouras J. The trimebutine effect on Helicobacter pylori-related gastrointestinal tract and brain disorders: A hypothesis. Neurochem Int 2021;144:104938. [PMID: 33535070 DOI: 10.1016/j.neuint.2020.104938] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
8 Anfinogenova ND, Quinn MT, Schepetkin IA, Atochin DN. Alarmins and c-Jun N-Terminal Kinase (JNK) Signaling in Neuroinflammation. Cells 2020;9:E2350. [PMID: 33114371 DOI: 10.3390/cells9112350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 崔海梦, 罗庆锋, 许乐. 幽门螺旋杆菌与胃外疾病相关性研究进展. 世界华人消化杂志 2015; 23(14): 2221-2227 [DOI: 10.11569/wcjd.v23.i14.2221] [Reference Citation Analysis]
10 Kountouras J, Polyzos SA, Katsinelos P, Anastasiadis S, Tzivras D, Doulberis M, Venizelos I, Vardaka E, Kountouras C, Deretzi G. Potential Impact of Helicobacter Pylori on Hepatic Encephalopathy Pathophysiology. Dig Dis Sci 2018;63:1087-8. [DOI: 10.1007/s10620-018-4911-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
11 Hollmann A, Martinez M, Maturana P, Semorile LC, Maffia PC. Antimicrobial Peptides: Interaction With Model and Biological Membranes and Synergism With Chemical Antibiotics. Front Chem 2018;6:204. [PMID: 29922648 DOI: 10.3389/fchem.2018.00204] [Cited by in Crossref: 96] [Cited by in F6Publishing: 86] [Article Influence: 32.0] [Reference Citation Analysis]
12 Han M, Chen J, Tsai M, Liou J, Chiou J, Chiu M, Chen Y. Association between Helicobacter pylori infection and cognitive impairment in the elderly. Journal of the Formosan Medical Association 2018;117:994-1002. [DOI: 10.1016/j.jfma.2017.11.005] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 2.3] [Reference Citation Analysis]
13 Doulberis M, Papaefthymiou A, Srivastava DS, Exadaktylos AK, Katsinelos P, Kountouras J, Polyzos SA. Update on the association between non-alcoholic fatty liver disease and Helicobacter pylori infection. Int J Clin Pract 2021;75:e13737. [PMID: 32991019 DOI: 10.1111/ijcp.13737] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
14 Kazakos EI, Kountouras J, Polyzos SA, Deretzi G. Novel aspects of defensins’ involvement in virus-induced autoimmunity in the central nervous system. Medical Hypotheses 2017;102:33-6. [DOI: 10.1016/j.mehy.2017.02.020] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
15 Boziki M, Polyzos SA, Deretzi G, Kazakos E, Katsinelos P, Doulberis M, Kotronis G, Giartza-Taxidou E, Laskaridis L, Tzivras D. A potential impact of Helicobacter pylori-related galectin-3 in neurodegeneration. Neurochem Int. 2018;113:137-151. [PMID: 29246761 DOI: 10.1016/j.neuint.2017.12.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 3.5] [Reference Citation Analysis]
16 Polyzos SA, Papaefthymiou A, Doulberis M, Mavridoglou G, Kountouras J. Helicobacter pylori infection and diabetes mellitus. Diabetes Metab Syndr 2021;15:845-6. [PMID: 33873053 DOI: 10.1016/j.dsx.2021.03.034] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
17 Deretzi G, Gavalas E, Boziki M, Tsiptsios D, Polyzos SA, Venizelos I, Zavos C, Koutlas E, Tsiptsios I, Katsinelos P, Kountouras J. Impact of Helicobacter pylori on multiple sclerosis-related clinically isolated syndrome. Acta Neurol Scand 2016;133:268-75. [DOI: 10.1111/ane.12453] [Cited by in Crossref: 12] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
18 Xu Y, Wang Q, Liu Y, Cui R, Zhao Y. Is Helicobacter pylori infection a critical risk factor for vascular dementia? International Journal of Neuroscience 2016;126:899-903. [DOI: 10.3109/00207454.2015.1081387] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 3.0] [Reference Citation Analysis]
19 da Costa JP, Cova M, Ferreira R, Vitorino R. Antimicrobial peptides: an alternative for innovative medicines? Appl Microbiol Biotechnol 2015;99:2023-40. [PMID: 25586583 DOI: 10.1007/s00253-015-6375-x] [Cited by in Crossref: 108] [Cited by in F6Publishing: 95] [Article Influence: 18.0] [Reference Citation Analysis]
20 Doulberis M, Kountouras J, Rogler G. Reconsidering the "protective" hypothesis of Helicobacter pylori infection in eosinophilic esophagitis. Ann N Y Acad Sci 2020;1481:59-71. [PMID: 32770542 DOI: 10.1111/nyas.14449] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
21 Doulberis M, Polyzos SA, Papaefthymiou A, Katsinelos P, Kountouras J. Comments to the Editor concerning the paper entitled "The microbiome and ophthalmic disease" by Baim et al. Exp Biol Med (Maywood) 2019;244:430-2. [PMID: 30654636 DOI: 10.1177/1535370218824340] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
22 Doulberis M, Kotronis G, Gialamprinou D, Polyzos SA, Papaefthymiou A, Katsinelos P, Kountouras J. Alzheimer's disease and gastrointestinal microbiota; impact of Helicobacter pylori infection involvement. Int J Neurosci 2021;131:289-301. [PMID: 32125206 DOI: 10.1080/00207454.2020.1738432] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
23 Kazakos EI, Dorrell N, Polyzos SA, Deretzi G, Kountouras J. Comment on “Effect of biofilm formation by clinical isolates of Helicobacter pylori on the efflux-mediated resistance to commonly used antibiotics”. World J Gastroenterol 2017; 23(33): 6194-6196 [PMID: 28970736 DOI: 10.3748/wjg.v23.i33.6194] [Cited by in CrossRef: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]